Wednesday, October 14, 2009

FierceBiotech: On the Radar: Keep an eye on these biotech stocks

Fierce Biotech says to keep an eye on these biotech stocks:

Human Genome Sciences (HGSI) $19.16

Auxilium Pharmaceuticals (AUXL) $34.70

Inspire Pharmaceuticals (ISPH) $5.57


GTx (GTXI) $10.75


Poniard Pharmaceuticals (PARD) $.6.92

Posted by at

3 comments:

  1. AnonymousOctober 15, 2009 at 9:36 AM

    what's your opinon about HRRN?
    - PENDING CONFERENCE TODAY AT 2PM,
    - ONLY 200 MILLION OUTSTANDING SHARES,
    - pps VALUED AT 0.035 BEFORE THEY GOT A PRIVATE SWISS BANK
    - in intensive negotiations to acquire a long time established Barter Company with monthly sales volumes over 350,000 Euros,
    . ALREADY received several business offers and trade opportunities FROM Government Commerce Departments and trade agents?

    ReplyDelete
  2. AnonymousOctober 15, 2009 at 3:02 PM

    check this out ma man

    About Biomagnetics Diagnostics Corporation

    BMGP is an advanced medical device and biotechnology company. Our revolutionary diagnostics system tests for any viral, or bacterial disease using any body fluid. Initial tests will include HIV, Hepatitis B, H-Pylori, and HPV. Our system will detect the presence of viruses/bacterium itself, not antibodies produced by the body’s immune system, which may take weeks/months to appear. This allows for earlier detection and treatment, while delivering the tests at a fraction of current costs. Biomagnetics plans to have products in use in China by the end of 2010 followed by US and European sales in 2011.

    Biomagnetics Diagnostics Corporation

    Sizing the Market and Assessing New Diagnostic Technologies & Opportunities

    * Biomagnetics Diagnostics Corp. (OTCPK: BMGP) is a California-based developer of advanced next generation medical diagnostic systems and technologies.

    * The Company’s HTS-MTP diagnostic platform is unique in the industry for its use of advanced magnetics to detect actual pathogens such as a virus, bacteria or fungi, rather than just the antibodies. It can test any bodily fluid and provides qualitative and quantitative results in one diagnostic tests, saving valuable time and money.

    * The Company is in advanced discussions with one of the premier U.S. government research institutions to acquire the rights for an advanced integrated optical biosensor system (IOBS) that utilizes lasers to quickly detect pathogens in human and animal blood samples.

    * While the new IOBS technology will be able to diagnose a number of diseases, the Company plans to target the very large global malaria testing market in which some 3.2 billion people are at risk. Currently, there are very few reliable, field applicable diagnostic tools available. It will also target the bovine TB market, with about 1.3 billion cattle worldwide.

    * The global health community desperately needs low-cost, easy-to-use, portable diagnostic tools to test for and prevent the spread of infectious diseases. Each year, between 14 million and 17 million people worldwide die from infectious diseases, most in developing countries.

    ReplyDelete
  3. AnonymousOctober 15, 2009 at 3:03 PM

    * While it is very difficult to place a target valuation on a pre-revenue company, we believe the uniqueness of Biomagnetics Diagnostics’ technology and the significant market demand likely to develop upon product availability places the total potential valuation of this company in excess of $40 million, possibly higher if a major diagnostic testing company became interested in acquiring this revolutionary technology platform.

    * Thus, we place the total potential market capitalization of Biomagnetics Diagnostics somewhere between $40 million and $60 million.

    * This implies a target price for these shares of approximately $0.75 to $1.10 at the end of 2009 when the Company’s integrated optical biosensor system for malaria and bovine tuberculosis testing is expected to become available in the marketplace.


    Biomagnetics Continues Contract Talks With U.S. Government's Premier National Security Research Institution
    http://finance.yahoo.com/news/Biomagnetics-Continues-bw-2589577645.html?x=0&.v=1

    Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology
    http://finance.yahoo.com/news/Biomagnetics-Diagnostics-bw-3160287022.html?x=0&.v=1

    Biomagnetics Diagnostics Corp. Appoints Charles Gregoire de Rothschild Special Adviser to Board
    http://finance.yahoo.com/news/Biomagnetics-Diagnostics-Corp-bw-816590573.html?x=0&.v=1

    Small Diagnostics Company Aims To Change Lab Field Testing (OTC:BMGP)
    http://biomedreports.com/articles/most-popular/12852-diagnostics-company-aims-to-change-lab-field-testing-otcbmgp.html

    Biomagnetics Diagnostics Corp. (OTC:BMGP), today released preliminary details of their 2009 Financing Blueprint.
    http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41215527

    Biomagnetics Enters into Agreement with One of China’s Largest Dairies
    http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41811699


    Biomagnetics Diagnostics Corp. to Enter Integrated Optical Biosensor System (IOBS) Market 9/8/2009
    http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41322849

    ReplyDelete

Subscribe to: Post Comments (Atom)